This trialstudies a new combo treatment for Glioblastoma, a malignant brain tumor. Patients will receive a 2 week combination of radiotherapy and a drug, then have surgery and continue with the drug.
2 Primary · 0 Secondary · Reporting Duration: 2 years
Side Effects for
1 Treatment Group
1 of 1
12 Total Participants · 1 Treatment Group
Primary Treatment: Treatment · No Placebo Group · Phase < 1
Who is running the clinical trial?
Age 18+ · All Participants · 7 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Is enrolment for this experiment still accessible?
"Clinicaltrials.gov indicates that this research study is presently searching for participants, with initial posting on September 21st 2022 and the most recent edit occurring November 2nd 2022." - Anonymous Online Contributor
How extensive is the current participation in this clinical experiment?
"Affirmative. Clinicaltrials.gov corroborates that this trial is actively seeking participants, having been first listed on September 21st 2022 and modified most recently on November 2nd 2022. This study requires a total of 12 patients from 1 medical centre." - Anonymous Online Contributor